Search
for
Sort by
Research 151–180 of 426
- Spanlastic-laden nanogel as a plausible platform for dermal delivery of bimatoprost with superior cutaneous deposition and hair regrowth efficiency in androgenic alopecia
- The role of fractional laser‐assisted drug delivery in enhancing the efficacy of topical bimatoprost solution in the treatment of alopecia areata: An intra‐patient comparative randomized clinical trial
- Topical Bimatoprost (0.03%) Versus Topical Mometasone Furoate (0.1%) in Treatment of Alopecia Areata
- Bimatoprost versus clobetasol propionate in scalp alopecia areata: A prospective non-randomized open-label clinical trial
- [Bimatoprost promotes hair growth of reconstructed hair follicles in mice through activation of the Wnt/β-catenin signaling pathway].
- Bimatoprost for Hair Loss: Initial Studies and Application
- Bimatoprost in androgenic alopecia dermatologic treatment
- Long-term safety and efficacy of Latisse (bimatoprost 0.03% solution) for treatment of eyelash hypotrichosis in subjects with chemotherapy induced and idiopathic hypotrichosis
- Bimatoprost in the treatment of eyelash hypotrichosis
- Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata
- Bimatoprost potentiates hair growth via Akt/Wnt/β-catenin signaling by targeting the KATP channels
- The Effect of Topical Bimatoprost 0.03% Solution on Androgenic Alopecia
- Bimatoprost for the treatment of female androgenetic alopecia—A case report
- Fractional Resurfacing and Topical Bimatoprost for the Treatment of Laser Induced Postinflammatory Hypopigmentation on the Lower Extremities
- A PROSPECTIVE CASE SERIES OF EYEBROWS ALOPECIA AREATA TREATMENT WITH 20% TCA APPLICATION ALONG WITH TOPICAL BIMATOPROST SOLUTION AT SHADAN INSTITUTE OF MEDICAL SCIENCES.
- The Efectiveness of 0.03% Bimatoprost Solution Vs Minoxidil 5% in Androgenic Alopecia
- Alopecia Areata: Current Treatments and New Directions
- Recent Progress in Prostaglandin F<sub>2</sub><i><sub>α</sub></i>Ethanolamide (Prostamide F<sub>2</sub><i><sub>α</sub></i>) Research and Therapeutics
- Topical and intralesional therapies for alopecia areata
- Hair Biology
- New onset of alopecia areata in a patient with SARS‐CoV‐2 infection: Possible pathogenetic correlations?
- The Latest Innovations in Hair Transplantation
- Harnessing the Power of Regenerative Therapy for Vitiligo and Alopecia Areata
- New drugs under investigation for the treatment of alopecias
- Treatments options for alopecia
- Phosphodiesterase inhibitors and prostaglandin analogues in dermatology: A comprehensive review
- Fallberichte
- Diseases of Periocular Hair
- Management of Hypotrichosis of the Eyelashes
- Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming?